In SLE, chronic activation of pDCs and other cells results in enhanced IFN-α and IFN-α/β receptor (IFN-α/βR) signaling on target cells (Rönnblom and Eloranta, 2013). Here, IFNA1 is linked to systemic lupus erythematosus.